Guest guest Posted March 28, 2011 Report Share Posted March 28, 2011 MolecularMD was founded by Druker. Zavie News from Business Wire This press release was issued via BusinessWire.com. Go to www.BusinessWire.com <http://www.businesswire.com> for additional news - registration<http://www.businesswire.com/portal/site/home/index.jsp?epi-content=\ BW_WIZARD_POPUP_TYPE & beanStrID=bwprofile & wizardName=userreg & viewID=MY_PORTAL_VIE\ W & redirectURL=/portal/site/home/>is free and quick! March 28, 2011 07:35 AM Eastern Daylight Time ARIAD And MolecularMD Announce Collaboration for a Companion Diagnostic Test for The T315I BCR-ABL Mutation in Patients With CML<http://www.businesswire.com/news/home/20110328005408/en/ARIAD-MolecularMD-An\ nounce-Collaboration-Companion-Diagnostic-Test> <http://www.businesswire.com/news/home/20110328005408/en/ARIAD-MolecularMD-Annou\ nce-Collaboration-Companion-Diagnostic-Test>CAMBRIDGE, Mass. & PORTLAND, Ore.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. <http://cts.businesswire.com/ct/CT?id=smartlink & url=http%3A%2F%2Fwww.ariad.com%2\ F & esheet=6660914 & lan=en-US & anchor=ARIAD+Pharmaceuticals%2C+Inc.+ & index=1 & md5=0af\ 6f3d1c751b2bfb62b2828e389fa23>(NASDAQ: ARIA) and MolecularMD Corporation today announced an exclusive collaboration agreement in which MolecularMD will develop and commercialize a companion diagnostic test to identify the T315I mutation of the BCR-ABL gene in patients with chronic myeloid leukemia (CML) and Philadelphia positive (Ph+) acute lymphoblastic leukemia (ALL). ARIAD is advancing its investigational, pan-BCR-ABL inhibitor, ponatinib, in the pivotal PACE trial of patients with resistant or intolerant CML and Ph+ ALL, or those with the T315I mutation. MolecularMD has performed BCR-ABL mutation testing with its standardized and validated sequencing test in patients enrolled in ARIAD’s earlier Phase 1 trial of ponatinib and now is cond... *Read the full news release on BusinessWire.com *<http://www.businesswire.com/news/home/20110328005408/en/ARIAD-MolecularMD-Anno\ unce-Collaboration-Companion-Diagnostic-Test> Business Wire features breaking news from leading companies and organizations worldwide. We invite you to set up your free news profile personalized to your interests. Register now at www.BusinessWire.com<http://www.businesswire.com> .. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.